Abbott Pharmaceuticals

'Abbott Pharmaceuticals' - 13 News Result(s)

  • After Pfizer, High Court Grants Relief to Abbott and Macleods
    Business | Thomson Reuters | Tuesday March 15, 2016
    Pharma majors Abbott Healthcare and Macleods Pharmaceuticals on Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.
    www.ndtv.com/business
  • Like Corex, Cough Syrup Phensedyl Is Banned, Makers Will Go To Court
    Business | Agencies | Monday March 14, 2016
    The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.
    www.ndtv.com/business
  • Government Caps Price of 18 Formulation Packs
    Business | Press Trust of India | Wednesday August 26, 2015
    The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.
    www.ndtv.com/business
  • Biocon Says May Demerge Syngene in Long Run, Post IPO
    Business | Thomson Reuters | Thursday July 16, 2015
    Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
    www.ndtv.com/business
  • India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
    India News | Reuters | Monday July 14, 2014
    India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
    www.ndtv.com
  • Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit
    Business | Monday July 14, 2014
    The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.
    www.ndtv.com/business
  • Not facing any significant IPR challenges in India: Abbott Pharma
    Business | Friday April 25, 2014
    American pharmaceutical giant Abbott has told the US government that it is not facing any significant challenge on intellectual property rights in India, as is being alleged by a section of industry here.
    www.ndtv.com/business
  • Big Pharma down, not out, after Novartis patent blow
    Business | Wednesday April 3, 2013
    Stung by a landmark patent defeat, Western drug-makers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016.
    www.ndtv.com/business
  • Prescribe a drug maker's medicine and get a free vacation
    Business | Monday September 17, 2012
    Consider the guide's entry for Nupod, an Abbott antibiotic generically known as cefpodoxime. It lists a medical textbook, a mosquito repellant and a coffee maker as incentives for doctors.
    www.ndtv.com/business
  • How India's 'free medicine to all' policy transforms lives
    Business | Thursday July 5, 2012
    From city hospitals to tiny rural clinics, India's public doctors will soon be able to prescribe free generic drugs to all comers.
    www.ndtv.com/business
  • Abbott Labs agrees to pay $1.5 billion over Depakote
    Business | Tuesday May 8, 2012
    Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. The company has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the drug for uses that were not approved by the FDA.
    www.ndtv.com/business
  • Elder Pharma weighs sale of nutrition business
    Business | Monday May 7, 2012
    Sources said the drugmaker is looking for a valuation of $60 million - $75 million for the business, and that discussions are at a very early stage. However, Joint Managing Director Alok Saxena denied that they were looking to sell the business.
    www.ndtv.com/business
  • Piramal to raise R&D spend for cancer drugs' trials
    Business | Wednesday June 6, 2012
    Drugmaker Piramal Healthcare's research and development (R&D) spend will significantly rise this fiscal year as it looks to initiate the second phase of clinical trials for at least two oncology molecules
    www.ndtv.com/business

'Abbott Pharmaceuticals' - 1 Video Result(s)

'Abbott Pharmaceuticals' - 13 News Result(s)

  • After Pfizer, High Court Grants Relief to Abbott and Macleods
    Business | Thomson Reuters | Tuesday March 15, 2016
    Pharma majors Abbott Healthcare and Macleods Pharmaceuticals on Tuesday got interim relief from the Delhi High Court which stayed till March 21 Government's decision banning sale of certain combination medicines of the two companies.
    www.ndtv.com/business
  • Like Corex, Cough Syrup Phensedyl Is Banned, Makers Will Go To Court
    Business | Agencies | Monday March 14, 2016
    The Delhi High Court has said that for now, a government ban on popular cough syrup Corex, made by US pharma Pfizer, will not hold. The court will next hear the case on Monday.
    www.ndtv.com/business
  • Government Caps Price of 18 Formulation Packs
    Business | Press Trust of India | Wednesday August 26, 2015
    The government has brought 18 more drugs, used to treat cancer, inflammation and infections, among others, under price control as part of its efforts to make life saving medicines affordable in the country.
    www.ndtv.com/business
  • Biocon Says May Demerge Syngene in Long Run, Post IPO
    Business | Thomson Reuters | Thursday July 16, 2015
    Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
    www.ndtv.com/business
  • India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
    India News | Reuters | Monday July 14, 2014
    India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
    www.ndtv.com
  • Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit
    Business | Monday July 14, 2014
    The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.
    www.ndtv.com/business
  • Not facing any significant IPR challenges in India: Abbott Pharma
    Business | Friday April 25, 2014
    American pharmaceutical giant Abbott has told the US government that it is not facing any significant challenge on intellectual property rights in India, as is being alleged by a section of industry here.
    www.ndtv.com/business
  • Big Pharma down, not out, after Novartis patent blow
    Business | Wednesday April 3, 2013
    Stung by a landmark patent defeat, Western drug-makers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016.
    www.ndtv.com/business
  • Prescribe a drug maker's medicine and get a free vacation
    Business | Monday September 17, 2012
    Consider the guide's entry for Nupod, an Abbott antibiotic generically known as cefpodoxime. It lists a medical textbook, a mosquito repellant and a coffee maker as incentives for doctors.
    www.ndtv.com/business
  • How India's 'free medicine to all' policy transforms lives
    Business | Thursday July 5, 2012
    From city hospitals to tiny rural clinics, India's public doctors will soon be able to prescribe free generic drugs to all comers.
    www.ndtv.com/business
  • Abbott Labs agrees to pay $1.5 billion over Depakote
    Business | Tuesday May 8, 2012
    Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. The company has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the drug for uses that were not approved by the FDA.
    www.ndtv.com/business
  • Elder Pharma weighs sale of nutrition business
    Business | Monday May 7, 2012
    Sources said the drugmaker is looking for a valuation of $60 million - $75 million for the business, and that discussions are at a very early stage. However, Joint Managing Director Alok Saxena denied that they were looking to sell the business.
    www.ndtv.com/business
  • Piramal to raise R&D spend for cancer drugs' trials
    Business | Wednesday June 6, 2012
    Drugmaker Piramal Healthcare's research and development (R&D) spend will significantly rise this fiscal year as it looks to initiate the second phase of clinical trials for at least two oncology molecules
    www.ndtv.com/business

'Abbott Pharmaceuticals' - 1 Video Result(s)

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com